Trans T-tube cholangial drainage (TTCD) demonstrates superior outcomes for bile leakage management at biliary-enteric anastomosis, achieving a technical success rate of 100% compared to 88.9% with percutaneous transhepatic cholangial drainage (PTCD). Both techniques reduced bilirubin levels significantly; however, the TTCD group experienced less intraoperative bleeding, fewer complications, reduced radiation exposure, and shorter hospital stays. Additionally, […]
Category: General Surgery
Location-specific lymph node dissection improves survival in esophageal cancer
Clinicians established that for early-stage esophageal squamous cell carcinoma, dissection of at least 17 lymph nodes significantly boosts survival rates. Tailored recommendations emerged based on tumor location: upper thoracic tumors require 19 lymph nodes, middle thoracic 17, and lower thoracic 18. Multivariate analysis identified total and lower mediastinal lymph nodes as critical independent prognostic factors. […]
Terminal ileal vein approach improves outcomes in laparoscopic surgery
A novel terminal ileal vein (TIV) approach enhances identification of the superior mesenteric vein during laparoscopic right hemicolectomy, leading to improved surgical outcomes. In a study of 196 patients, the TIV method resulted in significantly shorter operation times (186 vs. 210 minutes) and reduced intraoperative blood loss (50 vs. 70 ml). Patients also experienced shorter […]
Cyanoacrylate glue significantly lowers anastomotic leak rates.
Application of glubran 2, a cyanoacrylate-based sealant, in ileocolic anastomoses during right colectomy significantly reduced anastomotic leak (AL) rates from 6.18% to 1.85% (p
Routine imaging improves survival in pancreatic cancer patients post-surgery
A nationwide analysis involving 1,311 patients revealed that routine imaging after resection of pancreatic ductal adenocarcinoma significantly enhances overall survival. Patients undergoing routine imaging had a median overall survival of 43 months, compared to just 22 months for those monitored symptomatically. Additionally, routine imaging was strongly linked to the early detection of asymptomatic recurrence and […]
Long-acting resorbable meshes outperform other types in hernia repairs
Long-acting resorbable meshes exhibited the best long-term performance in ventral hernia repairs, with a median time-to-recurrence of 166.4 months, significantly longer than synthetic (132.1 months) and biologic meshes (80 months). Recurrence rates within five years were highest for biologic meshes (41%), dropping to 22% for long-acting resorbable meshes. The findings also suggest tailored follow-up schedules, […]
Grading Management Model Reduces Risks in Laparoscopic Cholecystectomy
A novel grading management model for laparoscopic cholecystectomy significantly lowers the conversion to open surgery and complications. The study, conducted with two Shanghai hospitals, identified key risk factors and developed a reliable scoring system with a notable area under the curve of 0.893. Scores above 3 indicate higher surgical risk, allowing clinicians to implement tailored […]
Laparoscopic hernia repair improves recovery in elderly patients
In a randomized trial involving 120 elderly patients, laparoscopic inguinal hernia repair showed significant benefits over traditional open surgery. Recovery times were notably shorter, with patients returning to normal activities within 7.5 days compared to 10.6 days for the open group (p
Circulation-first approach reduces mortality in trauma patients
A systematic review and meta-analysis involving 11,855 trauma patients revealed that prioritizing circulation over airway management significantly lowers mortality rates in cases of exsanguinating injuries. The analysis demonstrated a pooled odds ratio of 3.65 for increased mortality associated with the traditional airway-breathing-circulation (ABC) approach, especially higher in prospective studies at 9.99. The findings urge a […]
Durvalumab improves event-free survival in gastric cancer
In a phase 3 trial involving 948 participants with resectable gastric or gastroesophageal junction adenocarcinoma, adding durvalumab to standard chemotherapy (flot) significantly enhanced two-year event-free survival (67.4% vs. 58.5%, p
